We were aware that a viral outbreak of COVID-19 within our workforce would present a real risk to our staff and customers, causing significant disruption to our businesses. We reviewed several testing companies and products with the goal to ensure Kolina could continue to operate safely.
Following a successful trial of Medusa 19’s Rapid Protein Saliva Test, we are now implementing a regular testing regime which will enable us to prioritise staff safety and remain operational in priority sectors during these unprecedented and challenging times.
Dr Kwame Nkrumah,
Technology Director
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.